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SUMMARY 
Cancer cachexia is characterised by selective depletion of skeletal muscle protein 
reserves. The ubiquitin-proteasome proteolytic pathway has been shown to be 
responsible for muscle wasting in a range of cachectic conditions including cancer 
cachexia. To establish the importance of this pathway in muscle wasting during cancer 
(and sepsis), a quantitative competitive RT-PCR (QcRT-PCR) method was developed to 
measure the mRNA levels of the proteasome sub units C2a and csp and the ubiquitin-
conjugating enzyme E2t4k· Western blotting was also used to measure the 20S 
proteasome and E214k protein expression. In vivo studies in mice bearing a cachexia-
inducing murine colon adenocarcinoma (MAC16) demonstrated the effect of 
progressive weight loss on the mRNA and protein expression for 20S proteasome 
subunits, as well as the ubiquitin-conjugating enzyme, E214k, in gastrocnemius and 
pectoral muscles. QcRT-PCR measurements showed a good correlation between 
expression of the proteasome subunits (C2 and CS) and the E2t4k enzyme mRNA and 
weight loss in gastrocnemius muscle, where expression increased with increasing 
weight loss followed by a decrease in expression at higher weight losses (25-27%). 
Similar results were obtained in pectoral muscles, but with the expression being several 
fold lower in comparison to that in gastrocnemius muscle, reflecting the different 
degrees of protein degradation in the two muscles during the process of cancer 
cachexia. Western blot analysis of 20S and E2t4k protein expression followed a similar 
pattern with respect to weight loss as that found with mRNA. In addition, mRNA and 
protein expression of the 20S proteasome subunits and E214k enzyme was measured in 
biopsies from cachectic cancer patients, which also showed a good correlation between 
weight loss and proteasome expression, demonstrating a progressive increase in 
expression of the proteasome subunits and E2t4k mRNA and protein in cachectic 
patients with progressively increasing weight loss. 
The effect of the cachexia-inducing tumour product PIF (proteolysis inducing factor) 
and 15-hydroxyeicosatetraenoic acid (15-HETE), the arachidoinic acid metabolite 
(thought to be the intracellular transducer of PIF action) has also been determined. 
Using a surrogate model system for skeletal muscle, C2C12 myotubes in vitro, it was 
shown that both PIF and 15-HETE increased proteasome subunit expression (C2a and 
CSp) as well as the E2t4k enzyme. This increase gene expression was attenuated by pre-
incubation with EPA or the 15-lipoxygenase inhibitor CV-6504; immunoblotting also 
confrrmed these fmdings. Similarly, in sepsis-induced cachexia in NMRI mice there 
was increased mRNA and protein expression of the 20S proteasome subunits and the 
E2t4k enzyme, which was inhibited by EPA treatment. These results suggest that 15-
HETE is the intracellular mediator for PIF induced protein degradation in skeletal 
muscle, and that elevated muscle catabolism is accomplished through upregulation of 
the ubiquitin-proteasome-proteolytic pathway. Furthermore, both EP A and CV -6504 
have shown anti-cachectic properties, which could be used in the future for the 
treatment of cancer cachexia and other similar catabolic conditions. 
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